Dutasteride

The prostate gland depends on a hormone called dihydrotestosterone (DHT) for its growth ^{[1, 2]}. DHT is made from testosterone by an enzyme called 5-alpha reductase. In men with BPH, the prostate continues to grow over time, gradually pressing on the urethra and causing urinary symptoms — weak stream, frequent urination, difficulty starting urination, and nighttime waking to urinate.

Dutasteride blocks both types of the 5-alpha reductase enzyme (type 1 and type 2), reducing DHT levels in the blood by approximately 90% and in the prostate by approximately 94% ^[1]. This is more complete DHT suppression than finasteride, which blocks only type 2.

With dramatically less DHT available, the prostate gradually shrinks — typically by about 25% over 6-12 months of treatment ^{[1, 2]}. As the prostate gets smaller, pressure on the urethra decreases, and urinary symptoms improve. This process takes time — most men do not notice meaningful improvement until 3-6 months of consistent daily use.

Months 1-3: DHT levels decrease rapidly, but prostate size changes slowly ^[1]. You are unlikely to notice significant urinary symptom improvement during the first 3 months. Continue taking the medication daily as prescribed. Some men experience decreased libido or erectile changes early in treatment.

Months 3-6: Prostate volume reduction becomes measurable, and urinary symptoms begin to improve ^{[1, 2]}. You may notice improved urine flow, less frequent urination, and fewer nighttime awakenings.

Months 6-12: Substantial prostate size reduction (approximately 25%) and continued improvement in urinary symptoms ^{[1, 2]}. Clinical trials showed significant improvements in symptom scores, maximum urine flow rate, and reduced risk of acute urinary retention.

Long-term (1-4 years): The CombAT trial showed that dutasteride plus tamsulosin provided greater long-term symptom improvement and reduced disease progression compared to either drug alone over 4 years ^[2]. Benefits are maintained with continued use.

Dutasteride has minimal food interactions ^[1].

Food: May be taken with or without food. Food does not significantly affect absorption ^[1].

Alcohol: No specific drug-alcohol interaction is documented. Moderate alcohol consumption does not affect dutasteride's efficacy or safety.

Important handling note: Dutasteride soft gelatin capsules should not be handled by women who are pregnant or may become pregnant ^[1]. The drug can be absorbed through the skin and may cause birth defects in a male fetus. If a capsule leaks, wash the contact area immediately with soap and water.

Dutasteride dosing is simple ^[1].

BPH (monotherapy): - Dose: 0.5 mg once daily ^[1] - No dose titration required - Swallow capsules whole — do not crush, chew, or open

BPH (combination with tamsulosin — Jalyn): - Dutasteride 0.5 mg + tamsulosin 0.4 mg once daily ^[1] - Take approximately 30 minutes after the same meal each day

No dose adjustments needed for: - Renal impairment (any severity) ^[1] - Mild to moderate hepatic impairment (use caution in severe; not specifically studied) - Elderly patients ^[1]

Duration: Dutasteride requires at least 6 months of continuous daily use to assess therapeutic response ^[1]. Treatment is typically long-term/indefinite for BPH.

PSA monitoring: Dutasteride reduces serum PSA levels by approximately 50% within 3-6 months ^[1]. When interpreting PSA values in men taking dutasteride, multiply the measured PSA by 2 for comparison with normal ranges. Any confirmed increase in PSA during treatment should be evaluated, even if still in the 'normal' range.

Dutasteride is available as a generic medication ^{[1, 3]}.

Typical pricing (approximate 2025 prices): - Brand-name Avodart: $8-12 per capsule ($240-360/month) - Generic dutasteride: $0.30-1.50 per capsule ($9-45/month)

Savings strategies: - Generic substitution: Generic dutasteride has been available since 2015 ^[3]. Most prescriptions are now filled generically. - Pharmacy discount programs: GoodRx and similar programs can reduce generic prices to as low as $10-20/month. - Insurance: Most insurance plans cover generic dutasteride with low copays. - Combination product: If taking both dutasteride and tamsulosin, the combination product (generic Jalyn) may be more cost-effective than two separate prescriptions.

Pregnancy: Dutasteride is contraindicated in women and children ^[1]. It is classified with a specific warning that women who are pregnant or may become pregnant must not handle dutasteride capsules, as the drug can be absorbed through the skin and may cause abnormalities of the external genitalia in a male fetus (hypospadias). Men taking dutasteride should not donate blood until at least 6 months after their last dose, because the blood could be given to a pregnant woman through transfusion.

Breastfeeding: Not applicable — dutasteride is not indicated for use in women ^[1].

Generic dutasteride has been available since 2015 ^[3].

Brand name (Avodart): - Manufactured by GlaxoSmithKline - Soft gelatin capsules: 0.5 mg

Generic dutasteride: - Multiple manufacturers produce FDA-approved generics - Available as 0.5 mg soft gelatin capsules - Rated therapeutically equivalent by the FDA

Combination product: - Jalyn (dutasteride 0.5 mg + tamsulosin 0.4 mg): available generically since 2018

Comparison with finasteride (Proscar): - Finasteride blocks only type 2 5-alpha reductase; dutasteride blocks both type 1 and type 2 - Dutasteride achieves greater DHT suppression (~90% vs ~70%) - Both are effective for BPH; clinical differences are modest - Dutasteride has a much longer half-life (~5 weeks vs ~6-8 hours) - Finasteride is also available as 1 mg tablets for male pattern baldness (Propecia); dutasteride is not FDA-approved for hair loss but is sometimes used off-label